검색
Neurosense Therapeutics Ltd
NRSN관심 목록에 추가
0.723USD
+0.003+0.42%
종가 07/01, 16:00（ET）시세는 15분 지연됩니다
23.54M시가총액
손실P/E TTM
자세한 내용은 Neurosense Therapeutics Ltd 회사
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Neurosense Therapeutics Ltd 정보
종목 코드 NRSN
회사 이름Neurosense Therapeutics Ltd
상장일Dec 09, 2021
CEOBen-Noon (Alon)
직원 수15
유형Ordinary Share
회계 연도 종료Dec 09
주소11 Hamenofim St.
도시HERZLIYA
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Israel
우편 번호4672562
전화97297996183
웹사이트https://www.neurosense-tx.com/
종목 코드 NRSN
상장일Dec 09, 2021
CEOBen-Noon (Alon)
Neurosense Therapeutics Ltd의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
4.43M
+5.65%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
1.50M
+16.62%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
617.63K
+69.30%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
325.95K
+80.37%
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
207.90K
+88.46%
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Caren Deardorf
Ms. Caren Deardorf
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Revital Mandil-Levin, Ph.D.
Dr. Revital Mandil-Levin, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
4.43M
+5.65%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
1.50M
+16.62%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
617.63K
+69.30%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
325.95K
+80.37%
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
207.90K
+88.46%
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
자주 묻는 질문
Neurosense Therapeutics Ltd의 상위 5대 주주는 누구인가요?
Neurosense Therapeutics Ltd의 상위 5대 주주는 다음과 같습니다: Mr. Alon Ben-Noon
Neurosense Therapeutics Ltd(NRSN)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Neurosense Therapeutics Ltd의 주식을 보유한 기관은 총 33곳이며, 이들이 보유한 주식의 총 가치는 약 367.79K로 전체 발행 주식의 1.04%를 차지합니다. 이는 2025Q4 대비 -2009158.00 증가한 수치입니다.